
Tuesday, May 30, 2023 3:12:16 PM
There is a difference between establishing internal manufacturing versus setting a cdmo up owned by the ceo's fund. Big difference.
yup but they keep on calling it NWBO's CDMO whereas the owner is Toucan, not NWBO. If NWBO owned Advent we would now after MIA be at $ 3 a share.
The fantasy story now is its better for NWBO to start and fund a third-party CDMO from scratch than to contract an existing third-party CDMO with tens of years of experience 4 billion in revenue and 21000 employees because somewhere another biotech got rejected by the FDA.
hahahaha
Liked By
Spread the love. Be the first to like this post!
Recent NWBO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
- Nightfood, Inc. (OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands • InvestorsHub NewsWire • 03/13/2023 11:35:55 AM
- Northwest Bio Accuses Market Makers of Share Price Manipulation • TipRanks • 12/01/2022 03:29:04 PM
FEATURED SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split • Sep 27, 2023 9:49 AM
FEATURED 1606 Corp. Partners with Cool Blue To Launch ChatCBD, a New AI Customer Experience • Sep 26, 2023 8:37 AM
Branded Legacy Inc. Invests Heavily in Innovation and Growth with $540,000 Expansion • BLEG • Sep 26, 2023 10:37 AM
Avant Technologies Reshaping Future of Supercomputing and AI with Disruptive Private Cloud Infrastructure • AVAI • Sep 26, 2023 8:45 AM
Image Protect Announces Debt Forgiveness in Excess of $1,400,000 Clearing the Path for Pending New Business Development • IMTL • Sep 26, 2023 8:16 AM
CGrowth Capital Inc. Nears Key Milestone in Lithium Mining Expansion • CGRA • Sep 26, 2023 8:08 AM